The iShares Biotechnology ETF (Symbol: IBB) experienced a significant $114.2 million outflow, marking a 1.3% decrease in shares outstanding from 48,700,000 to 48,050,000 in the past week. The data was recorded as of [insert date], affecting key components such as Regeneron Pharmaceuticals, Inc. (down 0.8%), argenx SE (down 2.9%), and Insmed Inc. (down 0.7%).
IBB has a 52-week range of $116.25 to $179.64, with its last trade at $175.04. This drop in outstanding shares could lead to selling pressure on the underlying holdings, highlighting the importance of monitoring ETF inflows and outflows for investor strategies.
